Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Assets (2020 - 2025)

Biofrontera has reported Current Assets over the past 6 years, most recently at $18.1 million for Q4 2025.

  • For Q4 2025, Current Assets fell 12.64% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $18.1 million, down 12.64%, while the annual FY2025 figure was $18.1 million, 12.64% down from the prior year.
  • Current Assets for Q4 2025 was $18.1 million at Biofrontera, up from $14.4 million in the prior quarter.
  • Over five years, Current Assets peaked at $48.5 million in Q3 2022 and troughed at $10.1 million in Q3 2021.
  • A 5-year average of $27.6 million and a median of $20.7 million in 2024 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: surged 378.38% in 2022 and later crashed 46.51% in 2023.
  • Year by year, Current Assets stood at $46.4 million in 2021, then fell by 7.07% to $43.1 million in 2022, then crashed by 46.51% to $23.1 million in 2023, then fell by 10.29% to $20.7 million in 2024, then fell by 12.64% to $18.1 million in 2025.
  • Business Quant data shows Current Assets for BFRI at $18.1 million in Q4 2025, $14.4 million in Q3 2025, and $18.8 million in Q2 2025.